The "Leucine Rich Adaptor Protein 1 Like" (LRAP1L) is a protein that, by its name, suggests a role as an adaptor protein within cellular signaling pathways. Adaptor proteins typically do not have enzymatic activity but rather serve as platforms to bring together various proteins to facilitate signal transduction, thereby influencing a multitude of cellular processes.The nomenclature "leucine-rich" implies that LRAP1L contains leucine-rich repeats (LRRs), a structural motif involved in protein-protein interactions. LRRs are typically 20-30 amino acid stretches enriched in leucine and form a horseshoe-like shape, facilitating the formation of complexes with other proteins. These motifs are often implicated in the assembly of signaling complexes, and their presence in LRAP1L suggests a role in the selective recruitment of signaling molecules to specific cellular locations or pathways.
As an adaptor protein, LRAP1L could potentially interact with membrane-bound receptors, cytoplasmic kinases, or other adaptor proteins, thus modulating downstream signaling cascades. For example, it might participate in the regulation of immune responses by interfacing with receptors on immune cells, influencing the activation and differentiation of these cells.Additionally, given the "like" descriptor in its name, LRAP1L may share homology with a known leucine-rich adaptor protein but with distinct features that confer unique functional properties. These properties might include altered binding affinities, subcellular localization, or expression patterns in different tissues or developmental stages.While the specific biological functions of LRAP1L remain speculative without empirical data, the presence of leucine-rich motifs and its classification as an adaptor protein suggest that it plays a significant role in mediating and fine-tuning signal transduction pathways, impacting cell behavior, and maintaining cellular homeostasis. Its involvement might be critical in contexts where precise cellular responses are required, such as in development, immune regulation, or cellular stress responses.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), affecting signaling pathways associated with cell growth and survival. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, used to block PI3K-dependent signaling pathways involved in cell proliferation and survival. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, affecting the MAPK/ERK pathway, which is involved in cell growth and differentiation processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, used to study the role of p38 MAPK in inflammation and stress response pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, impacting signaling pathways related to apoptosis, inflammation, and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Specifically inhibits mTOR, affecting cell growth, proliferation, and survival pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src family kinase inhibitor, affecting various signaling pathways involved in cell growth and survival. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Another Src family kinase inhibitor, used to study Src-dependent signaling processes. | ||||||
Cdc2-Like Kinase Inhibitor, TG003 | 300801-52-9 | sc-202528 sc-202528A | 5 mg 25 mg | $139.00 $548.00 | 6 | |
Inhibits RSK (ribosomal S6 kinase), affecting downstream signaling of the ERK pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cell shape, motility, and proliferation by modulating the actin cytoskeleton. | ||||||